The Wharton Moneyball Post Game Podcast

Share

Wharton Moneyball: MLB Bryce Harper Contract, NBA March Madness, & Sports Betting

Ep. 140

Show from 3/6/19


In this episode of Wharton Moneyball Eric Bradlow switches things up and co-hosts the show with Co-President of D&H Distributing and returning guest Daniel Schwab! They jump right into the MLB news about the pros and cons of Bryce Harper's Contract with the Philadelphia Phillies. Then they bring on NBC Sports expert on the NBA, Tom Haberstroh, to to talk about LeBron James, the Lakers, the NBA Playoffs, and March Madness! Plus more MLB and some sports betting with Neil Greenberg of the Washington Post. Check it out


Guests:

Tom Haberstroh is the NBC Sports National NBA Insider and the host of the Habershow podcast. He is an expert in NBA analytics, sports science, player health.

Follow him on twitter @tomhaberstroh 


Neil Greenberg is a staff writer with The Washington Post whose beat is sports analytics. His analysis and insight can be found on the Fancy Stats blog, where he covers all pro sports, as well as college football and basketball.

Follow him on twitter @ngreenberg 

Check out his stories here: https://www.washingtonpost.com/people/neil-greenberg/?utm_term=.6c0bb442b3d0


More Episodes

7/22/2020

7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.